Founded in 2023, Xi’an Zhibang Beishan Pharmaceutical Technology Co., Ltd. is a distinctive CRO, providing high-quality, comprehensive one-stop services and contract manufacturing for domestic clients. Its services include medical writing, clinical trials, data management, statistical analysis, predicate device comparison, third-party auditing, clinical trial consulting and regulatory registration, aiming to help clients shorten time-to-market, reduce R&D costs, improve clinical trial quality and accelerate product commercialization. Technical Strengths: The company has 5 drug evaluation experts, 2 medical device evaluation experts, 1 GMP inspection expert and 1 GCP inspection expert. All evaluation experts have over 6 years of experience in evaluation centers, reviewing more than 100 projects annually on average, with over 700 projects and 80 on-site inspections per expert. Talent Strengths: Its team of evaluation, medical and regulatory consultants covers 90% of indications and high-profile products. It helps design scientific trials that meet regulatory requirements, are more likely to yield positive results, and cost less.